摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯吡啶甲酰胺盐酸盐 | 1179360-43-0

中文名称
3-氯吡啶甲酰胺盐酸盐
中文别名
——
英文名称
3-chloropyridine-2-carboximidamide hydrochloride
英文别名
3-Chloropicolinimidamide hydrochloride;3-chloropyridine-2-carboximidamide;hydrochloride
3-氯吡啶甲酰胺盐酸盐化学式
CAS
1179360-43-0
化学式
C6H6ClN3*ClH
mdl
——
分子量
192.048
InChiKey
OHCTVSVXORSCHH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.44
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.8
  • 氢给体数:
    3
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    ethyl 2-[4-chloro-3-(trifluoromethyl)benzyl]-4,4,4-trifluoro-3-oxobutanoate 、 3-氯吡啶甲酰胺盐酸盐potassium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 反应 1.0h, 以75%的产率得到2-(3-chloropyridin-2-yl)-5-[4-chloro-3-(trifluoromethyl)benzyl]-6-(trifluoromethyl)pyrimidin-4(3H)-one
    参考文献:
    名称:
    TW2016/5831
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE
    申请人:BAYER PHARMA AKTIENGESELLSCHAFT
    公开号:US20160237059A1
    公开(公告)日:2016-08-18
    The present application relates to novel heterocyclically substituted 6-(trifluoromethyl)pyrimidin-4(3H)-one derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular, renal, inflammatory and fibrotic diseases.
    本申请涉及新颖的杂环取代的6-(三氟甲基)嘧啶-4(3H)-酮衍生物,其制备方法,它们单独或组合用于治疗和/或预防疾病,以及它们用于制备用于治疗和/或预防疾病的药物,特别是用于治疗和/或预防心血管、肾脏、炎症和纤维化疾病。
  • 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
    申请人:Alonso-Alija Cristina
    公开号:US20060293326A1
    公开(公告)日:2006-12-28
    The invention relates to 2-Heteroaryl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R 1 denotes 5- to 10-membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C 1 -C 4 )-alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3- to 10-membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, whereby carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C 1 -C 6 )-aldyl, (C 1 -C 6 )-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C 2 -C 10 )-alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C 1 -C 6 )-alkoxy, hydroxy, halogen, 3- to 10-membered carbocyclyl and oxo.
    本发明涉及2-杂环芳基咪唑三嗪酮的制备方法及其在药物中的应用,特别是用于治疗和/或预防炎症过程和/或免疫性疾病。本发明涉及通式(I)的化合物,其中R1表示5-至10-成员杂环芳基,该杂环芳基可以被选自卤素,(C1-C4)-烷基,三氟甲基,氰基,硝基和三氟甲氧基的相同或不同残基取代,或表示3-至10-成员碳环烷基或碳键结合的4-至10-成员杂环烷基,其中碳环烷基和杂环烷基可以被选自(C1-C6)-醛基,(C1-C6)-醛氧基,羟基,卤素,三氟甲基和氧代物的相同或不同残基取代,或表示(C2-C10)-烷基,该烷基可以被选自(C1-C6)-氧烷基,羟基,卤素,3-至10-成员碳环烷基和氧代物的相同或不同残基取代。
  • 2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES
    申请人:Bayer HealthCare AG
    公开号:EP1399439A1
    公开(公告)日:2004-03-24
  • USE OF A COMPOSITION COMPRISING METAL COMPLEX COMPOUNDS AND POLYPHOSPHONATES AS CATALYSTS FOR OXIDATIONS
    申请人:Ciba Specialty Chemicals Holding Inc.
    公开号:EP1703977A1
    公开(公告)日:2006-09-27
  • [EN] 2-HETEROARYL-IMIDAZOTRIAZINONES AND THEIR USE IN THE TREATMENT OF INFLAMMATORY OR IMMUNE DISEASES<br/>[FR] 2-HETEROARYL-IMIDAZOTRIAZINONES ET UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES OU IMMUNITAIRES
    申请人:BAYER AG
    公开号:WO2002098873A1
    公开(公告)日:2002-12-12
    The invention relates to 2-Heteroaryl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases. The present invention relates to compounds of the general formula (I) in which R1 denotes 5- to 10- membered heteroaryl, which is optionally substituted by identical or different residues selected from the group consisting of halogen, (C¿1?-C4)-alkyl, trifluoromthyl, cyano, nitro und trifluoromethoxy, denotes 3-to 10-membered carbocyclyl or carbon-bonded, 4- to 10-membered heterocyclyl, whereby carbocyclyl and heterocyclyl are optionally substituted by identical or different residues selected from the group consisting of (C1-C6)-aldyl, (C1-C6)-aldoxy, hydroxy, halogen, trifluoromethyl and oxo, or denotes (C2-C10)-alkyl, which is optionally substituted by identical or different residues selected from the group the group consisting of (C1-C6)-alkoxy, hydroxy, halogen, 3-to 10-membered carbocyclyl and oxo.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-